Skip to main content
Download PDF

Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer

Journal of Experimental & Clinical Cancer Research volume 35, Article number: 95 (2016) Cite this article

The Original Article was published on 22 April 2016

Erratum

Unfortunately, the original version of this article [1] contained an error. The name of one of the authors, Sharad Sharma, was not included in the author list.

The correct author list and the new “Authors’ contributions” section have been correctly included in full in this erratum and updated in the original article.

References

  1. 1.

    Feng L, Yao HP, Sharma S, Zhou YQ, Zhou J, Zhang R, et al. Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer. J Exp Clin Cancer Res. 2016;35(1):70. doi:10.1186/s13046-016-0347-6.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

    Affiliations

    1. State Key Laboratory for Diagnosis & Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases, First Hospital of Zhejiang University School of Medicine, Zhejiang, China

      Liang Feng, Hang-Ping Yao & Ming-Hai Wang

    2. Department of Biomedical Sciences, Texas Tech University Health Sciences Center School of Pharmacy, 1406 Coulter Street, Suite 1117, Amarillo, TX, 79106, USA

      Liang Feng, Hang-Ping Yao, Sharad Sharma & Ming-Hai Wang

    3. Department of Neurosurgery, First Hospital of Zhejiang University School of Medicine, Zhejiang, China

      Yong-Qing Zhou

    4. Department of Molecular Cell Biology & Toxicology, Nanjing Medical University School of Public Health, Jiangsu, China

      Jianwei Zhou

    5. Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, TX, USA

      Ruiwen Zhang

    Authors
    1. Liang Feng
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Hang-Ping Yao
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Sharad Sharma
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Yong-Qing Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Jianwei Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Ruiwen Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Ming-Hai Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Ming-Hai Wang.

    Additional information

    Authors’ contributions

    LF and HPY contribute equally to this work. LF was involved in preparation of antibody-drug conjugation, some in vitro and in vivo studies related to NSCLC. SS was involved in antibody characterization, some in vitro studies related to breast cancer. HPY and YQZ produced and purified anti-RON antibody, participated in some in vitro experiment, analyzed data, and provided partial funds for this project. JWZ provided experimental design and technical support for some intro experiments. RWZ participated in experimental design for combination study. MHW designed the study, participated in data analysis, wrote the manuscript, and secured the fund for completion of this study. All authors read and approved the final manuscript.

    The online version of the original article can be found under doi:10.1186/s13046-016-0347-6.

    Rights and permissions

    Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Feng, L., Yao, HP., Sharma, S. et al. Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer. J Exp Clin Cancer Res 35, 95 (2016). https://doi.org/10.1186/s13046-016-0364-5

    Download citation

    Journal of Experimental & Clinical Cancer Research

    ISSN: 1756-9966

    Contact us